Antibiotic resistance: safeguarding progress and taking targeted action
Bern, 17.11.2026 — Switzerland has made important progress in the appropriate use of antibiotics in recent years. The new Swiss Antibiotic Resistance Report 2026 (SARR 2026) shows that antibiotic consumption is low compared with other European countries, while many resistance levels remain stable or low. The aim remains to use antibiotics appropriately and only when necessary, avoiding unnecessary treatment. Particularly problematic forms of antibiotic resistance must be detected early and their spread contained.
The Swiss Antibiotic Resistance Report (SARR) is a key instrument of the Swiss Strategy on Antibiotic Resistance (StAR) and the StAR One Health Action Plan 2024-2027. Published every two years, the report brings together data from human and veterinary medicine and the environmental sector, following a One Health approach. It shows how antibiotic use and resistance are developing, where measures are having an effect and where further action is needed.
More targeted and less frequent antibiotic use
Human medicine: In 2025, antibiotic consumption had already fallen below the target set for 2027 in the StAR Action Plan. At the same time, new analyses show that the quality of antibiotic prescriptions can be further improved: for around one fifth of the prescriptions recorded in the Sentinella surveillance system, the antibiotic chosen was not in line with prescribing guidelines.
Veterinary medicine: Distribution and prescribing data for 2024 and 2025 confirm the decline in the use of antibiotics observed over several years. For the first time, a slight decrease has been recorded in cattle across all categories and indicators. However, antibiotic use in cattle remains considerably higher than in pigs and poultry. Further reductions are needed, particularly in dairy cattle and veal production, without compromising animal health or welfare.
Measures to promote targeted and appropriate antibiotic use must be given greater priority. In human medicine, half of all hospitals already have a formal antibiotic stewardship programme in place. Small-animal veterinary practices now receive practice-specific evaluations that allow them to compare their antibiotic use in cats and dogs with that of similar practices. Efforts to optimise antibiotic use through such tools must continue.
Focus on common and hard-to-treat resistances
Using antibiotics too frequently or inappropriately can promote the emergence and spread of resistant bacteria. This can make treatments less effective or even ineffective. For many important pathogens, resistance levels in Switzerland are stable or declining.
Human medicine: The proportion of methicillin-resistant Staphylococcus aureus (MRSA) has declined considerably over the long term. However, certain developments indicate that further action is still needed. Resistance in Escherichia coli (E. coli) to certain broad-spectrum antibiotics has increased. As E. coli infections are common, they contribute substantially to the burden of disease. Carbapenem-resistant Enterobacterales (CRE) are also becoming more common, although they remain rare. Their limited treatment options and potential for spread require particular attention. Early detection and consistent infection prevention and control are essential.
Veterinary medicine: Antibiotic resistance is monitored in bacterial pathogens from sick animals, in bacteria from healthy animals at slaughter and in bacteria found in fresh meat sold at retail. This surveillance supports animal health while also detecting resistance that may be relevant to human health through food or contact with animals. Despite varying trends, resistance rates have remained broadly stable in recent years. CRE continue to be undetected in the monitored Swiss livestock and in the retail meat samples tested.
Monitoring of humans, animals and the environment highlights the impact of measures and the need for further action
Antibiotic resistance monitoring is continuously being developed across all sectors. New data sources and additional analyses help to identify trends early and assess the effectiveness of measures. In human medicine, health insurance claims data have been analysed for the first time to provide a more detailed picture of outpatient antibiotic prescribing by medical specialty and canton.
Further information and analyses are available from ANRESIS, the Swiss Centre for Antibiotic Resistance, and on the FOPH’s Infectious Diseases Dashboard, where they are easily accessible and clearly presented. In veterinary medicine, analyses of prescribing data are now also presented in a dashboard. They show how antibiotic use is developing by animal species and production category, helping to identify areas where further action is needed.
In the environmental sector, antibiotic residues and other micropollutants are monitored in surface waters throughout Switzerland. The River Glatt in the canton of St. Gallen provides an example of the effectiveness of such measures: following upgrades to wastewater treatment, measured concentrations of several antibiotics declined substantially.
StAR: tackling antibiotic resistance together
The Swiss Strategy on Antibiotic Resistance (StAR) brings together measures taken by the FOPH, the FSVO, the FOAG and the FOEN. The StAR One Health Action Plan 2024-2027 strengthens measures to combat antibiotic resistance in humans, animals and the environment.
From 18 to 24 November 2026, World Antimicrobial Resistance Awareness Week (WAAW), will raise awareness of antimicrobial resistance in Switzerland and internationally and promote the appropriate use of antibiotics. During a webinar, specialists will present the findings of the Swiss Antibiotic Resistance Report 2026 and answer questions about current challenges.
Links
Swiss Antibiotic Resistance Report 2026
Focus: Antibiotic prescribing in retirement and nursing homes
Focus: Benchmarking antibiotic use in cats and dogs
Focus: Antibiotics and antimicrobial resistance in the water cycle
Overview of key figures: Antibiotic use and resistance
Background: Monitoring systems overview
Data and dashboards on antibiotic use and resistance: